Document is current

Article History

Received: 30 March 2026

Accepted: 11 July 2026

First Online: 7 August 2026

Declarations

Ethics approval and consent to participate: Not applicable.

Consent for publication: Not applicable.

Competing interests: FG reported support from AOP Health related to the present manuscript; honoraria for lectures from AOP Health, Baxter, Chiesi, Edwards, Masimo, Orion, OrphaSwisse, and Viatris; participation on a Data Safety Monitoring Board or Advisory Board for AOP Health, Orion and Viatris. BL reported honoraria for lectures and support for attending meetings and/or travel from AOP Health. MB reported honoraria for lectures and participation on a Data Safety Monitoring Board or Advisory Board for AOP Health. MF reported support related to the present manuscript, honoraria for lectures and payment for expert testimony from AOP Health; participation on a Data Safety Monitoring Board or Advisory Board for AOP Health. MJ received research grants by Baxter and Fresenius. He also received consulting fees from AmPharma, Baxter, Biomerieux, Novartis and Sphingotec and honoraria for lectures from AOP Health, Baxter, Biomerieux and Vantive. DM declares no competing interests. SR received support related to the present manuscript, consulting fees, honoraria for lectures and support for attending meetings and/pr travel from AOP Health. He also received honoraria for lectures from CSL Behring. MS received support for the present manuscript, grants or contracts, consulting fees, honoraria for lectures, support for attending meetings and/or travel from AOP Health. He also participated on an Advisory Board for AOP Health and received drugs from AOP Health.